Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Liver Failure × Everolimus × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 91 Carcinoma, Renal Cell 65 Neoplasm Metastasis 40 Neoplasms 33 Neuroendocrine Tumors 31 Kidney Neoplasms 24 Recurrence 16 Prostatic Neoplasms 16 Carcinoma, Non-Small-Cell Lung 16 Tuberous Sclerosis 14 Triple Negative Breast Neoplasms 13 Head and Neck Neoplasms 13 Glioblastoma 12 Carcinoma, Hepatocellular 12 Pancreatic Neoplasms 11 Lymphoma, Mantle-Cell 11 Lymphoma 11 Brain Neoplasms 11 Sarcoma 10 Lymphoma, Large B-Cell, Diffuse 10 Leukemia, Lymphocytic, Chronic, B-Cell 10 Hodgkin Disease 10 Colorectal Neoplasms 10 Carcinoma, Neuroendocrine 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Glioma 9 Waldenstrom Macroglobulinemia 8 Lymphoma, Follicular 8 Lung Neoplasms 8 Carcinoid Tumor 8

Interventions

urinastatin 1 sacituzumab govitecan 1 maltodextrin 1 halofantrine 1 Raltegravir Potassium 1 N-monoacetylcystine 1 Glycyrrhizic Acid 1 Everolimus 1 Blood Specimen Collection 1 Amino Acids 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01423708 2012-07-18

EPOCAL

Azienda Ospedaliera di Padova

Phase 2 Unknown

Gastrointestinal

Liver Cirrhosis, Liver Diseases, Liver Neoplasms, Liver Failure

Data powered by HemOnc (CC BY 4.0) Colophon ⚡